These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 33600081)

  • 1. Filler-induced granuloma from polycaprolactone-based collagen stimulator injection in the tear trough area: A case report.
    Chiang CH; Peng JH; Peng HP
    J Cosmet Dermatol; 2021 May; 20(5):1529-1531. PubMed ID: 33600081
    [No Abstract]   [Full Text] [Related]  

  • 2. Granuloma as a complication of polycaprolactone-based dermal filler injection: ultrasound and histopathology studies.
    Skrzypek E; Górnicka B; Skrzypek DM; Krzysztof MR
    J Cosmet Laser Ther; 2019; 21(2):65-68. PubMed ID: 29757038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polycaprolactone-based dermal filler complications: A retrospective study of 1111 treatments.
    Lin SL; Christen MO
    J Cosmet Dermatol; 2020 Aug; 19(8):1907-1914. PubMed ID: 32485052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo evaluation of novel particle-free polycaprolactone fillers for safety, degradation, and neocollagenesis in a rat model.
    Hong JY; Kim JH; Kwon TR; Hong JK; Li K; Kim BJ
    Dermatol Ther; 2021 Mar; 34(2):e14770. PubMed ID: 33421287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neocollagenesis in human tissue injected with a polycaprolactone-based dermal filler.
    Kim JA; Van Abel D
    J Cosmet Laser Ther; 2015 Apr; 17(2):99-101. PubMed ID: 25260139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study of rheological properties and preclinical data of porous polycaprolactone microsphere dermal fillers.
    Kim JS; In CH; Park NJ; Kim BJ; Yoon HS
    J Cosmet Dermatol; 2020 Mar; 19(3):596-604. PubMed ID: 31347766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of polycaprolactone and calcium hydroxylapatite dermal fillers in a rat model.
    Yanatma I; Sarac G; Gul M; Gul S; Kapicioglu Y
    Dermatol Ther; 2021 Jan; 34(1):e14716. PubMed ID: 33368862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late-Onset Filler-Induced Granuloma After Polycaprolactone-Based Filler Treated With High-Intensity Focused Ultrasound and Quantum Molecular Resonance Technology.
    Hong JK; Sun B; Shin SH; Kim BJ
    Dermatol Surg; 2022 Jun; 48(6):693-694. PubMed ID: 35363638
    [No Abstract]   [Full Text] [Related]  

  • 9. Biostimulatory effects of polydioxanone, poly-d, l lactic acid, and polycaprolactone fillers in mouse model.
    Kwon TR; Han SW; Yeo IK; Kim JH; Kim JM; Hong JY; Lee BC; Lee SE; Moon HS; Kwon HJ; Kim BJ
    J Cosmet Dermatol; 2019 Aug; 18(4):1002-1008. PubMed ID: 30985064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Evaluation of Physical Characteristics and Preclinical Data of a Novel Monodisperse Polycaprolactone Microspheres Filler.
    Oh H; Lee S; Na J; Kim BJ; Kim JH
    Aesthetic Plast Surg; 2022 Feb; 46(1):429-436. PubMed ID: 34302203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the efficacies of polycaprolactone filler and lidocaine-added filler on neocollagenesis in a rat model.
    Sezer S; Sarac G; Gul M; Zayman E; Kapicioglu Y
    J Cosmet Dermatol; 2022 Aug; 21(8):3327-3333. PubMed ID: 34894046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in Dermal Thickness in Biopsy Study of Histologic Findings After a Single Injection of Polycaprolactone-Based Filler into the Dermis.
    Kim JS
    Aesthet Surg J; 2019 Nov; 39(12):NP484-NP494. PubMed ID: 30778526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case report on dermal filler-related periorbital granuloma formation.
    Parulan MAA; Sundar G; Lum JH; Ramachandran U
    Orbit; 2019 Apr; 38(2):169-172. PubMed ID: 29842814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and Long-Term Efficacy of Forehead Contouring With a Polycaprolactone-Based Dermal Filler.
    Bae B; Lee G; Oh S; Hong K
    Dermatol Surg; 2016 Nov; 42(11):1256-1260. PubMed ID: 27662054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic reaction to polycaprolactone-based dermal filler: A case report.
    Pacetti L; Cavaliere S; Schettini N; Melloni L; Borghi A
    J Cosmet Dermatol; 2024 Mar; 23(3):1087-1088. PubMed ID: 37876338
    [No Abstract]   [Full Text] [Related]  

  • 16. Adverse reactions to injectable soft tissue fillers: memorable cases and their clinico-pathological overview.
    Lee SK; Kim SM; Cho SH; Lee JD; Kim HS
    J Cosmet Laser Ther; 2015 Apr; 17(2):102-8. PubMed ID: 25260141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioactive PCL microspheres with enhanced biocompatibility and collagen production for functional hyaluronic acid dermal fillers.
    Heo Y; Shin SW; Kim DS; Lee S; Park SY; Baek SW; Lee JK; Kim JH; Han DK
    Biomater Sci; 2022 Feb; 10(4):947-959. PubMed ID: 35043794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasound Morphology of Polycaprolactone Filler.
    Wortsman X; Quezada N
    J Ultrasound Med; 2017 Dec; 36(12):2611-2615. PubMed ID: 28703420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrasonography-guided curettage of poly-DL-lactic acid filler granulomas.
    Seok J; Kim JM; Kwon TR; Kim JH; Li K; Kim BJ
    J Am Acad Dermatol; 2018 Jan; 78(1):e5-e6. PubMed ID: 29241806
    [No Abstract]   [Full Text] [Related]  

  • 20. Filler migration to the forehead due to multiple filler injections in a patient addicted to cosmetic fillers.
    Lin CH; Chiang CP; Wu BY; Gao HW
    J Cosmet Laser Ther; 2017 Apr; 19(2):124-126. PubMed ID: 27813656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.